306 related articles for article (PubMed ID: 16418010)
1. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
2. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
[TBL] [Abstract][Full Text] [Related]
3. Applying proteomics technology to platelet research.
García A; Watson SP; Dwek RA; Zitzmann N
Mass Spectrom Rev; 2005; 24(6):918-30. PubMed ID: 15599945
[TBL] [Abstract][Full Text] [Related]
4. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
5. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
deVera IE; Katz JE; Agus DB
Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
[TBL] [Abstract][Full Text] [Related]
6. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
Faca V; Pitteri SJ; Newcomb L; Glukhova V; Phanstiel D; Krasnoselsky A; Zhang Q; Struthers J; Wang H; Eng J; Fitzgibbon M; McIntosh M; Hanash S
J Proteome Res; 2007 Sep; 6(9):3558-65. PubMed ID: 17696519
[TBL] [Abstract][Full Text] [Related]
7. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
[TBL] [Abstract][Full Text] [Related]
9. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics and biomarker discovery.
Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975
[TBL] [Abstract][Full Text] [Related]
11. Targeted proteomics in biomarker validation: detection and quantification of proteins using a multi-dimensional peptide separation strategy.
Immler D; Greven S; Reinemer P
Proteomics; 2006 May; 6(10):2947-58. PubMed ID: 16619308
[TBL] [Abstract][Full Text] [Related]
12. The amplified peptidome: the new treasure chest of candidate biomarkers.
Geho DH; Liotta LA; Petricoin EF; Zhao W; Araujo RP
Curr Opin Chem Biol; 2006 Feb; 10(1):50-5. PubMed ID: 16418009
[TBL] [Abstract][Full Text] [Related]
13. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples.
Levin Y; Schwarz E; Wang L; Leweke FM; Bahn S
J Sep Sci; 2007 Sep; 30(14):2198-203. PubMed ID: 17668910
[TBL] [Abstract][Full Text] [Related]
14. Human saliva proteome analysis.
Hu S; Loo JA; Wong DT
Ann N Y Acad Sci; 2007 Mar; 1098():323-9. PubMed ID: 17435138
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the mouse serum proteome.
Hood BL; Zhou M; Chan KC; Lucas DA; Kim GJ; Issaq HJ; Veenstra TD; Conrads TP
J Proteome Res; 2005; 4(5):1561-8. PubMed ID: 16212407
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Paul ion trap to the linear ion trap for use in global proteomics.
Riter LS; Gooding KM; Hodge BD; Julian RK
Proteomics; 2006 Mar; 6(6):1735-40. PubMed ID: 16475232
[TBL] [Abstract][Full Text] [Related]
17. So, you want to look for biomarkers (introduction to the special biomarkers issue).
LaBaer J
J Proteome Res; 2005; 4(4):1053-9. PubMed ID: 16083254
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
19. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
20. Proteomics in neurosciences.
Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
